Treatment of multiple sclerosis with rituximab: A Spanish multicenter experience.

Front Neurol · 2023 · PMC10027934 · PMID 36959824

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The OLYMPUS trial in PMS showed that RTX marginally reduced the time to CWD status, but the difference did not reach statistical significance except in a preplanned subgroup of young patients (<51 years of age with GEL in the baseline MRI) ( 13 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.